Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Secures US Patent For Cannabidiol Gel For Treating Fragile X Syndrome FDA Headlines
Mar 1, 2019 | Business. Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Secures U.S Patent For Cannabidiol Gel For Treating. Zynerba Pharmaceuticals Inc …